Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients

Clinical trial NCT00044538 · COMPLETED

Trial details

NCT number: NCT00044538
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2001-12-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.